medigraphic.com
ISSN 0185-3252 (Impreso)
Revista de la Asociación Médica del Centro Médico ABC

2002, Número 1

<< Anterior Siguiente >>

An Med Asoc Med Hosp ABC 2002; 47 (1)


Mecanismos neurohormonales, cardiovasculares y renales en la hipertensión arterial del obeso

Cano RC, Espinosa FR,Toiber GD

Idioma: Español
Referencias bibliográficas: 31
Paginas: 29-32
Archivo PDF: 36.73 Kb.


RESUMEN

La obesidad es un problema de salud pública mundial. En nuestro país está en franco aumento. Como consecuencia de esto, se hacen presentes sus complicaciones como la hipertensión arterial y sus secuelas. En este trabajo revisamos los mecanismos neurohormonales de la leptina, insulina, dopamina, norepinefrina, angiotensina y el óxido nítrico, así como las funciones cardiovasculares y renales que favorecen la hipertensión arterial en la obesidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rosembaum M, Leíble RL, Hirsch J. Obesity. N Eng J Med 1997; 337: 396-407.

  2. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643.

  3. Huber HB. The importance of obesity in the development of coronary risk factors and disease. Annu Rev Public Health 1986; 7: 493-502.

  4. Weindruch R, Sohal RS. Caloric intake and aging. N Eng J Med 1997; 337: 986-995.

  5. Willet WC, Dietz WH. Guidelines for healthy weight. N Eng J Med 1999; 341: 422-433.

  6. Zhang Y. Positional cloning of the mouse ob gene and its human homologue. Nature 1994; 372: 425-432.

  7. Ravussin E. Metabolic differences and the development of obesity. Metabolism 1995; 9 (suppl 3): 12-14.

  8. Barker DJ. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 1989; 298: 654-657.

  9. Hales CN. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 1991; 303: 1019-1022.

  10. Hall JE. Renal and cardiovascular mechanism of hypertension in obesity. Hypertension 1994; 23: 381-394.

  11. De Divitis O. Obesity and cardiac function. Circulation 1981; 64: 477-482.

  12. Ahima RS. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-252.

  13. Shek EW, Brands MW. Chronic leptin infusion increased arterial pressure. Hypertension 1998; 31: 409-414.

  14. Masuo K, Mikami H, Ogihara T. Weight gain induced blood pressure elevation. Hypertension 2000; 35: 1135-1140.

  15. Meehan WP, Buchanan TA. Chronic insulin administration elevates blood pressure in rats. Hypertension 1994; 23: 1012-1017.

  16. Heise T, Magnusson K. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension 1998; 32: 243-248.

  17. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension 1998; 32: 187-197.

  18. Neil TG, Tomlinson B, Critchley J. Modulation of blood pressure and obesity with the dopamine D2 receptor gene Taq 1 polymorphism. Hypertension 2000; 36: 177-182.

  19. Sowers JR, Nyby M. Dopaminergic control of prolactin and blood pressure. Hypertension 1982; 4: 431-438.

  20. Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992; 19: 67-77.

  21. Hall JE. Hyperinsulinemia: a link between obesity and hypertension? Kidney Int 1993; 43: 1402-1417.

  22. Kassab S, Kato T. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-897.

  23. Hunt SC, Cook NR, Oberman A. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension (TOHP). Hypertension 1998; 32: 393-401.

  24. Christian R, Nosratola V. Enhanced NO inactivation and hypertension induced by a high fat, refined carbohydrate diet. Hypertension 2000; 36: 423-429.

  25. Anca D, Michael D. Oxidative stress in a rat model of obesity induced hypertension. Hypertension 2001; 37: 554-560.

  26. Lausen JB, Rajagopalan S. Role of superoxide in angiotensin II induced but not catecholamine induced hypertension. Circulation 1997; 95: 588-593.

  27. Weisinger JR, Kempson RL. The nephrotic syndrome: A complication of massive obesity. Ann Intern Med 1974; 81: 440-447.

  28. Licata G, Volpe M. Salt regulating hormones in young normotensive obese subjects. Hypertension 1994; 23: 20-24.

  29. Kambham N, Markowitz G. Obesity related glomerulophaty. An emerging epidemic. Kidney Int 2001; 59: 1498-1509.

  30. Wolf G, Hamann A. Leptin stimulates proliferation and TGF-b expression in renal glomerular endothelial cells. Kidney Int 1999; 56: 860-872.

  31. Keane WF. Lipids and the kidney. Kidney Int 1994; 46: 910-920.




2020     |     www.medigraphic.com